PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21184671-11	2010	Similarly, ESBL- producing Klebsiella spp strains were significantly more resistance to cotrimoxazole (92.6%), ciprofloxacin (25.0%), nalidixic acid (66.2%), and gentamicin (38.2%) than strains that did not produce ESBL (P < 0.05).	Nalidixic Acid	134-148	EsbL	Escherichia coli	11-15	
21184671-10	2010	ESBL- producing E. coli strains were significantly more resistance to cotrimoxazole (90.7%), ciprofloxacin (46.3%) and nalidixic acid (61.6%) than strains that did not produce ESBL (p < 0.05).	Nalidixic Acid	119-133	EsbL	Escherichia coli	0-4	
19759473-7	2009	A significantly increased resistance rate to nalidixic acid, ciprofloxacin and gentamicin was observed in ESBL-nonproducing Enterobacteriaceae over the study period.	Nalidixic Acid	45-59	EsbL	Escherichia coli	106-110	
33203576-6	2021	We found that 87.1 % of the isolates were multidrug-resistant, including 9% ESBL-producers, with the highest rates to nalidixic acid (82 %), colistin (77 %), ticarcillin (76 %) and ampicillin (76 %).	Nalidixic Acid	118-132	EsbL	Escherichia coli	76-80